{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:42:51Z","timestamp":1792590171605,"version":"4.5.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ejmech.2026.119442","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:45:19Z","timestamp":1792230319000},"page":"119442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["AlphaFold-driven structure-based drug discovery: Capabilities, benchmarks and limitations for medicinal chemistry"],"prefix":"10.1016","volume":"321","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6272-9196","authenticated-orcid":false,"given":"Manish","family":"Pathak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119442_bib1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: new estimates of R&D costs","volume":"47","author":"DiMasi","year":"2016","journal-title":"J. Health Econ."},{"key":"10.1016\/j.ejmech.2026.119442_bib2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1042\/EBC20170052","article-title":"Structure-based drug design: aiming for a perfect fit","volume":"61","author":"van Montfort","year":"2017","journal-title":"Essays Biochem."},{"key":"10.1016\/j.ejmech.2026.119442_bib3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.chembiol.2003.09.002","article-title":"The process of structure-based drug design","volume":"10","author":"Anderson","year":"2003","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119442_bib4","doi-asserted-by":"crossref","first-page":"D488","DOI":"10.1093\/nar\/gkac1077","article-title":"RCSB protein data bank (RCSB.org): delivery of experimentally-determined PDB structures alongside one million computed structure models of proteins from artificial intelligence\/machine learning","volume":"51","author":"Burley","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.119442_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1042\/BST20180269","article-title":"Structural biology and structure\u2013function relationships of membrane proteins","volume":"47","author":"Reis","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejmech.2026.119442_bib7","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.cell.2014.10.051","article-title":"A glimpse of structural biology through X-ray crystallography","volume":"159","author":"Shi","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119442_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/protein\/12.2.85","article-title":"Twilight zone of protein sequence alignments","volume":"12","author":"Rost","year":"1999","journal-title":"Protein Eng."},{"key":"10.1016\/j.ejmech.2026.119442_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108620","article-title":"Overview of AlphaFold2 and breakthroughs in overcoming its limitations","volume":"176","author":"Wang","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.ejmech.2026.119442_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119442_bib11","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/prot.26237","article-title":"Critical assessment of methods of protein structure prediction (CASP)\u2014Round XIV","volume":"89","author":"Kryshtafovych","year":"2021","journal-title":"Proteins"},{"key":"10.1016\/j.ejmech.2026.119442_bib12","doi-asserted-by":"crossref","first-page":"D368","DOI":"10.1093\/nar\/gkad1011","article-title":"AlphaFold protein structure database in 2024: providing structure coverage for over 214 million protein sequences","volume":"52","author":"Varadi","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.119442_bib13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119442_bib14","article-title":"Protein complex prediction with AlphaFold-Multimer","author":"Evans","year":"2021","journal-title":"bioRxiv Prepr"},{"key":"10.1016\/j.ejmech.2026.119442_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41392-023-01381-z","article-title":"AlphaFold2 and its applications in the fields of biology and medicine","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2026.119442_bib16","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3390\/biom13081258","article-title":"Protein structure prediction in drug discovery","volume":"13","author":"Paiardini","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2026.119442_bib17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/biom14030339","article-title":"Advances in AI for protein structure prediction: implications for cancer drug discovery and development","volume":"14","author":"Qiu","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2026.119442_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2022.102526","article-title":"AlphaFold2 protein structure prediction: implications for drug discovery","volume":"78","author":"Borkakoti","year":"2023","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ejmech.2026.119442_bib19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nrd.2017.178","article-title":"Trends in GPCR drug discovery: new agents, targets and indications","volume":"16","author":"Hauser","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119442_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets","volume":"16","author":"Santos","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119442_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/pro.3022","article-title":"How cryo-electron microscopy and X-ray crystallography complement each other","volume":"26","author":"Wang","year":"2017","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2026.119442_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.sbi.2017.06.002","article-title":"Cryo-EM: beyond the microscope","volume":"46","author":"Earl","year":"2017","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ejmech.2026.119442_bib23","doi-asserted-by":"crossref","first-page":"22059","DOI":"10.1016\/S0021-9258(18)45665-7","article-title":"Protein structure determination in solution by NMR spectroscopy","volume":"265","author":"W\u00fcthrich","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119442_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.906437","article-title":"AlphaFold 2 and NMR spectroscopy: partners to understand protein structure, dynamics and function","volume":"9","author":"Laurents","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejmech.2026.119442_bib25","doi-asserted-by":"crossref","first-page":"8426","DOI":"10.3390\/ijms25158426","article-title":"AI-driven deep learning techniques in protein structure prediction","volume":"25","author":"Chen","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119442_bib26","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.3390\/ijms20092301","article-title":"Methods for the refinement of protein structure 3D models","volume":"20","author":"Adiyaman","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119442_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ejmech.2026.119442_bib28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/358086a0","article-title":"A new approach to protein fold recognition","volume":"358","author":"Jones","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119442_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nmeth.3213","article-title":"The I-TASSER suite: protein structure and function prediction","volume":"12","author":"Yang","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejmech.2026.119442_bib30","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nprot.2015.053","article-title":"The Phyre2 web portal for protein modeling, prediction and analysis","volume":"10","author":"Kelley","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2026.119442_bib31","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/nprot.2012.085","article-title":"Template-based protein structure modeling using the RaptorX web server","volume":"7","author":"K\u00e4llberg","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2026.119442_bib32","first-page":"1194","article-title":"Principles, challenges and advances in ab initio protein structure prediction, protein pept","volume":"19","author":"Jothi","year":"2012","journal-title":"Letture"},{"key":"10.1016\/j.ejmech.2026.119442_bib33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0076-6879(04)83004-0","article-title":"Protein structure prediction using Rosetta","volume":"383","author":"Rohl","year":"2004","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejmech.2026.119442_bib34","series-title":"Advances in Protein Molecular and Structural Biology Methods","first-page":"373","article-title":"Prediction, validation, and analysis of protein structures: a beginner's guide","author":"Sasidharan","year":"2022"},{"key":"10.1016\/j.ejmech.2026.119442_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4902","article-title":"Toward physics-based precision medicine: exploiting protein dynamics to design new therapeutics and interpret variants","volume":"33","author":"Meller","year":"2024","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2026.119442_bib36","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41586-023-06622-3","article-title":"Uncovering new families and folds in the natural protein universe","volume":"622","author":"Durairaj","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119442_bib37","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41586-019-1923-7","article-title":"Improved protein structure prediction using potentials from deep learning","volume":"577","author":"Senior","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119442_bib38","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/prot.26617","article-title":"Critical assessment of methods of protein structure prediction (CASP)\u2014Round XV","volume":"91","author":"Kryshtafovych","year":"2023","journal-title":"Proteins"},{"key":"10.1016\/j.ejmech.2026.119442_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2023.102543","article-title":"The opportunities and challenges posed by the new generation of deep learning-based protein structure predictors","volume":"79","author":"Varadi","year":"2023","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ejmech.2026.119442_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4379","article-title":"Benchmarking ALPHAFOLD for protein complex modeling reveals accuracy determinants","volume":"31","author":"Yin","year":"2022","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2026.119442_bib41","doi-asserted-by":"crossref","first-page":"56075","DOI":"10.1021\/acsomega.5c07675","article-title":"Improving stereochemical limitations in protein\u2013ligand complex structure prediction","volume":"10","author":"Ishitani","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2026.119442_bib42","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1021\/acs.jcim.5c03075","article-title":"Physical implausibility of carbohydrate ligands in results of deep learning-based cofolding methods","volume":"66","author":"Luthfi","year":"2026","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119442_bib43","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41467-025-67127-3","article-title":"Benchmarking all-atom biomolecular structure prediction with FoldBench","volume":"17","author":"Xu","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119442_bib44","article-title":"AlphaFold3 for structure-guided ligand discovery","author":"Menon","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.ejmech.2026.119442_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/science.adl2528","article-title":"Generalized biomolecular modeling and design with RoseTTAFold all-atom","volume":"384","author":"Krishna","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.119442_bib46","article-title":"Boltz-1: democratizing biomolecular interaction modeling","author":"Wohlwend","year":"2024","journal-title":"bioRxiv preprint"},{"key":"10.1016\/j.ejmech.2026.119442_bib47","article-title":"Chai-1: decoding the molecular interactions of life","author":"Chai","year":"2024","journal-title":"bioRxiv preprint"},{"key":"10.1016\/j.ejmech.2026.119442_bib48","article-title":"Boltz-2: towards accurate and efficient binding affinity prediction","author":"Passaro","year":"2025","journal-title":"bioRxiv preprint"},{"key":"10.1016\/j.ejmech.2026.119442_bib49","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1039\/D3SC04185A","article-title":"PoseBusters: AI-Based docking methods fail to generate physically valid poses or generalise to novel sequences","volume":"15","author":"Buttenschoen","year":"2024","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.119442_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn1524","article-title":"AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine\u2013associated receptor 1","volume":"10","author":"D\u00edaz-Holgu\u00edn","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.119442_bib51","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/s41594-022-00849-w","article-title":"A structural biology community assessment of AlphaFold2 applications","volume":"29","author":"Akdel","year":"2022","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2026.119442_bib52","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.89386.2","article-title":"How accurately can one predict drug binding modes using AlphaFold models?","volume":"12","author":"Karelina","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2026.119442_bib53","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1021\/acs.jcim.2c01219","article-title":"Benchmarking refined and unrefined AlphaFold2 structures for hit discovery","volume":"63","author":"Zhang","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119442_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117955","article-title":"Properties of protein drug target classes","volume":"10","author":"Bull","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.119442_bib55","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1038\/s41467-024-51801-z","article-title":"AlphaFold predictions of fold-switched conformations are driven by structure memorization","volume":"15","author":"Chakravarty","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119442_bib56","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41586-023-06832-9","article-title":"Predicting multiple conformations via sequence clustering and AlphaFold2","volume":"625","author":"Wayment-Steele","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119442_bib57","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.75751","article-title":"Sampling alternative conformational states of transporters and receptors with AlphaFold2","volume":"11","author":"Del Alamo","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.ejmech.2026.119442_bib58","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41592-023-02087-4","article-title":"AlphaFold predictions are valuable hypotheses and accelerate but do not replace experimental structure determination","volume":"21","author":"Terwilliger","year":"2024","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejmech.2026.119442_bib59","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2105-12-S4-S3","article-title":"Improving the prediction of disease-related variants using protein three-dimensional structure","volume":"12","author":"Capriotti","year":"2011","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ejmech.2026.119442_bib60","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1042\/EBC20200108","article-title":"Uncovering protein function: from classification to complexes","volume":"66","author":"Morris","year":"2022","journal-title":"Essays Biochem."},{"key":"10.1016\/j.ejmech.2026.119442_bib61","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/ci800324m","article-title":"Identifying and characterizing binding sites and assessing druggability","volume":"49","author":"Halgren","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119442_bib62","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1021\/acs.jcim.2c00947","article-title":"ProBiS-fold approach for annotation of human structures from the AlphaFold database with no corresponding structure in the PDB to discover new druggable binding sites","volume":"62","author":"Konc","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119442_bib63","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.drudis.2014.07.012","article-title":"Recent computational advances in the identification of allosteric sites in proteins","volume":"19","author":"Lu","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2026.119442_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbpa.2018.05.003","article-title":"Cryptic binding sites on proteins: definition, detection, and druggability","volume":"44","author":"Vajda","year":"2018","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119442_bib65","doi-asserted-by":"crossref","first-page":"8481","DOI":"10.1021\/acs.jcim.4c01475","article-title":"Challenge for deep learning: protein structure prediction of ligand-induced conformational changes at allosteric and orthosteric sites","volume":"64","author":"Olanders","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119442_bib66","doi-asserted-by":"crossref","DOI":"10.1126\/science.adn6354","article-title":"AlphaFold2 structures guide prospective ligand discovery","volume":"384","author":"Lyu","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.119442_bib67","doi-asserted-by":"crossref","unstructured":"X. Gu, A. Aranganathan, P. Tiwary, Empowering AlphaFold2 for protein conformation selective drug discovery with AlphaFold2-RAVE, eLife (2024) eLife 13:RP99702. https:\/\/doi.org\/10.7554\/eLife.99702.3.","DOI":"10.7554\/eLife.99702.3"},{"key":"10.1016\/j.ejmech.2026.119442_bib68","article-title":"Improving docking and virtual screening performance using AlphaFold2 multi-state modeling for kinases","volume":"14","author":"Song","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119442_bib69","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119442_bib70","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1021\/ja512751q","article-title":"Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field","volume":"137","author":"Wang","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119442_bib71","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.drudis.2007.07.006","article-title":"The role of quantum mechanics in structure-based drug design","volume":"12","author":"Raha","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2026.119442_bib72","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1021\/acs.jcim.2c00796","article-title":"Are deep learning structural models sufficiently accurate for free-energy calculations? Application of FEP+ to AlphaFold2-predicted structures","volume":"62","author":"Beuming","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119442_bib73","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1039\/D2SC05709C","article-title":"AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor","volume":"14","author":"Ren","year":"2023","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.119442_bib74","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.csbj.2025.05.002","article-title":"Identification of novel compounds against Trypanosoma cruzi using AlphaFold structures","volume":"27","author":"Ros-Lucas","year":"2025","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ejmech.2026.119442_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013274","article-title":"Highly accurate protein structure prediction-based virtual docking pipeline accelerating the identification of anti-schistosomal compounds","volume":"21","author":"Cheng","year":"2025","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2026.119442_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-21502-8","article-title":"PRosettaC outperforms AlphaFold3 for modeling PROTAC ternary complexes","volume":"15","author":"Schulz","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119442_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.70225","article-title":"AI-based prediction of PROTAC- and molecular glue-mediated ternary complexes: a comparative evaluation of AlphaFold 3 and Boltz-2","volume":"359","author":"Riepenhausen","year":"2026","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2026.119442_bib78","doi-asserted-by":"crossref","DOI":"10.15252\/msb.202211081","article-title":"Benchmarking AlphaFold-enabled molecular docking predictions for antibiotic discovery","volume":"18","author":"Wong","year":"2022","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.ejmech.2026.119442_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105920","article-title":"How good are AlphaFold models for docking-based virtual screening?","volume":"26","author":"Scardino","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.ejmech.2026.119442_bib80","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrd.2016.109","article-title":"Twenty years on: the impact of fragments on drug discovery","volume":"15","author":"Erlanson","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119442_bib81","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s44320-023-00005-6","article-title":"Systematic discovery of protein interaction interfaces using AlphaFold and experimental validation","volume":"20","author":"Lee","year":"2024","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.ejmech.2026.119442_bib82","first-page":"3782","article-title":"Predicting PROTAC-mediated ternary complexes with AlphaFold3 and Boltz-1, digit","volume":"4","author":"Dunlop","year":"2025","journal-title":"Discovery"},{"key":"10.1016\/j.ejmech.2026.119442_bib83","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s43588-024-00737-x","article-title":"Structure-based drug design with equivariant diffusion models","volume":"4","author":"Schneuing","year":"2024","journal-title":"Nat. Comput. Sci."},{"key":"10.1016\/j.ejmech.2026.119442_bib84","article-title":"Applications of AlphaFold beyond protein structure prediction","author":"Zhang","year":"2021","journal-title":"bioRxiv Prepr"},{"key":"10.1016\/j.ejmech.2026.119442_bib85","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.119442_bib86","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-biochem-061516-044518","article-title":"Protein misfolding diseases","volume":"86","author":"Hartl","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2026.119442_bib87","article-title":"Leveraging AlphaFold 3 for structural modeling of neurological disorder-associated proteins: a pathway to precision medicine","author":"Gadde","year":"2024","journal-title":"bioRxiv Prepr"},{"key":"10.1016\/j.ejmech.2026.119442_bib88","article-title":"Hallucinations in AlphaFold 3 for intrinsically disordered proteins with disorder in biological process residues","author":"Gopalan","year":"2025","journal-title":"arXiv Prepr"},{"key":"10.1016\/j.ejmech.2026.119442_bib89","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41586-024-07089-6","article-title":"Targeted protein degradation via intramolecular bivalent glues","volume":"627","author":"Hsia","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119442_bib90","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.tibs.2024.12.006","article-title":"Routes to molecular glue degrader discovery","volume":"50","author":"Liu","year":"2025","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2026.119442_bib91","doi-asserted-by":"crossref","first-page":"933","DOI":"10.13005\/ojc\/400403","article-title":"Personalized medicine: a comprehensive review","volume":"40","author":"Pandey","year":"2024","journal-title":"Orient. J. Chem."},{"key":"10.1016\/j.ejmech.2026.119442_bib92","doi-asserted-by":"crossref","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"Cheng","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.119442_bib93","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41597-024-03327-8","article-title":"Analysis of AlphaMissense data in different protein groups and structural context","volume":"11","author":"Tordai","year":"2024","journal-title":"Sci. Data"},{"key":"10.1016\/j.ejmech.2026.119442_bib94","article-title":"Benchmarking AlphaMissense against ClinVar for diagnostic interpretation of missense variants in inherited retinal diseases, ophthalmol","volume":"6","author":"Lindquist","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.119442_bib95","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.1021\/acs.jcim.5c00947","article-title":"Quantification of the impact of structure quality on predicted binding free energy accuracy","volume":"65","author":"Behera","year":"2025","journal-title":"J. Chem. Inf. Model."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:05:36Z","timestamp":1792587936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426008871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":94,"alternative-id":["S0223523426008871"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119442","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AlphaFold-driven structure-based drug discovery: Capabilities, benchmarks and limitations for medicinal chemistry","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119442"}}